livongo stock forecast 2020

Livongo Health Inc. stock price down 0% on Friday (Updated on December 11, 2020) Buy or Hold candidate since 2020-09-22 Gain 1.17% PDF . This marked an acceleration from 41% revenue growth in Q1 and 85% in Q2. Select Page. Even given their blowout performances, there were high expectations already built in, so Wall Street's reaction isn't that surprising. 8:05p DoorDash is worth more than $60 billion after IPO ; 7:52p Tom Siebel Is Back: An Interview With the CEO and Founder of C3.ai The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. CEO Zane Burke cited a number of high-profile business wins during the quarter, including Livongo's partnership with Fresenius Medical Care North America for chronic kidney disease and with Magellan Health for behavioral health patients. Posted on October 19, 2020 October 19, 2020 Author Michael O'Mahony Comments Off on Livongo Announces Date for Special Dividend From Teladoc Merger In a document filed on Friday, Livongo announced the date its existing shareholders can expect to be paid the special dividend arising from its merger with Teladoc. LVGO updated stock price target summary. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the LVGO stock was … The impressive growth was driven higher by the even more eye-popping increase in number of patient visits -- 2.8 million, up 206%. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy.". Long-term investors should stay focused on the massive opportunity ahead for these two healthcare companies that are disrupting the status quo. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the LVGO stock to lose ahead of the earnings release. Given his 2020 forecast of $ 300 million, that puts stock trades at 37 times the sales, which many companies are currently trading in our market, despite even larger GAAP losses. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. Shares in Livongo Health Inc are currently priced at $139.77. Information about the Livongo Health Inc Stock. Teladoc Health to merge with Livongo in $18.5B cash and stock deal Aug. 05, 2020 6:53 AM ET Teladoc Health, Inc. (TDOC) By: Gaurav Batavia , SA News Editor 331 Comments Given the impressive results, investors would normally be positively giddy at the prospect of triple-digit revenue growth. Skip to main navigation ... Livongo Reports Third Quarter 2020 Financial Results. The projections show that the combined company’s revenue will grow 2.57x from 2020 to 2022. In this case, Hooker thinks regulatory changes related to remote patient monitoring could create a new potential market for Livongo of around $15 billion annually. By Cromwell Schubarth – TechFlash Editor, ... 40 Under 40 2020 . That said, despite all the enthusiasm for the title, as next year approaches, Livongo’s revenue growth rates are expected to slow: Source: SA Premium Tools The average price target is $93.53, with a high forecast of $170.00 and a low forecast of $41.00. Livongo Health does not currently pay a dividend. Livongo Health last released its earnings results on October 28th, 2020. predictions are above 350. impressive to say the least . His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Teladoc's stock price and forecast On Oct. 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9 percent. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Livongo Health Shares Jumped Today @themotleyfool #stocks $LVGO. Revenues in 2020 of $1.339 billion (on a pro forma … This helped Livongo close out the quarter with an estimated value of agreements (EVA, previously known as "total contract value") of $146 million, up 71% year over year to reach a new record high. Figures show that Livongo Health, Inc. shares have underperformed across the wider relevant industry. In the short term (2weeks), LVGO's stock price should underperform the market by -1.48%.During that period the price should oscillate between -9.63% and +8.16%.. Livongo currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured employers, government agencies, and health plans. Market data powered by FactSet and Web Financial Group. Copyright, Trademark and Patent Information. Let's conquer your financial goals together...faster. Despite being -3.84% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Sep 10 when the LVGO stock price touched $131.62 or saw a rise of 7.52%. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. See you at the top! While each company delivered more than 100% top-line growth, both stocks sold off on the news, eventually recouping some of their losses and ending the day down roughly 4% each. So Why Are Their Stocks Down? Livongo Health has generated ($1.01) earnings per share over the last year. Just prior to earnings, Teladoc and Livongo were priced at 20 times and 51 times sales, respectively, when a reasonable price-to-sales ratio is between 1 and 2. So what's going on with these two healthcare disrupters? Teladoc reported revenue of $289 million, up 109% year over year. Livongo Health, Inc. () Stock Market info Recommendations: Buy or sell Livongo Health stock? That optimism could be well-founded. Given those parabolic increases, it's also important to point out that the companies' valuations had gotten a little stretched -- not unusual for high-risk, high-reward stocks. Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO), reported third-quarter earnings after the market close last Wednesday. LVGO forecast, Livongo Health's stock is owned by a number of institutional and retail investors. This price target is based on 17 analysts offering 12 month price targets for Livongo Health in the last 3 months. Livongo Health also reported stellar results. If met, this would reflect a huge 45% improvement in … 2020 Will Be a Year to Forget for These 3 Healthcare Stocks, The 1 Reason Why Teladoc Health and Livongo Were So Eager to Merge, Why This 1 Stock Could Bring Life-Changing Returns, Teladoc and Livongo Health Shareholders Approve the Companies' Merger, Copyright, Trademark and Patent Information. This resulted in an adjusted (non-GAAP) loss per share of $0.13, much better than the expected loss of $0.30. ... *Stock Advisor returns as of April 16, 2020 Livongo has a market cap of $12.72 Billion and is expected to release its quarterly earnings report on Nov 04, 2020- Nov 09, 2020. By Manas Mishra and Noor Zainab Hussain (Reuters) - Teladoc Health Inc (N: ... this stock is massive. Their forecasts range from $46.00 to $170.00. Hooker wrote to clients that KeyBanc sees Livongo "as a potential 'beat-and-raise' story through 2020 and 2021.". Stock Advisor launched in February of 2002. Its total client base also swelled, up 71% to 1,402. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.1. The biggest driver was stronger-than-expected enrollment in Livongo for Diabetes, the company's flagship program, which added 442,000 new members, up 113% year over year. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. This suggests that the stock has a possible downside of 20.6%. Livongo Health has tremendous growth prospects with its focus on diabetes and hypertension management. Third-quarter revenue climbed to $106.1 million, up 126% year over year and edging higher sequentially from 125% top-line growth in Q2 and 115% growth in Q1. After the latest results, the twelve analysts covering Livongo Health are now predicting revenues of US$299.5m in 2020. LVGO - Livongo Health Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Their success will be measured in years or even decades, not in any given quarter. Returns as of 12/15/2020. Look for the company to continue its expansion into behavioral health and other arenas as well. Livongo Health, Inc. (LVGO) estimates and forecasts. The company generated adjusted net income of $19.2 million and adjusted earnings per share of $0.16, up from an adjusted loss of $0.05 in the prior-year quarter. Returns as of 12/15/2020. Let's conquer your financial goals together...faster. The healthcare stock is priced at a premium, with shares trading at 33 times sales. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Livongo Health, Inc. (NASDAQ:LVGO) trade information. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. ... Teladoc bets big on online medicine with $18.5 billion Livongo deal By Reuters - Aug 05, 2020. Up 143% in 2020, Is Teladoc Health Still a Buy? Livongo Health, Inc. Stock Price Forecast, "LVGO" Predictons for2021 No changes to the price of Livongo Health Inc. stock on the last trading day (Friday, 11th Dec 2020). This easily topped analysts' consensus estimate of $95.6 million. Cumulative Growth of a $10,000 Investment in Stock Advisor, Teladoc and Livongo Demolished Expectations. The problem is TDOC stock already more than reflects the benefits of the merger and … In that case, then, we find that the current price level is +20.41% off the targeted high while a plunge would see the stock lose -61.05% from current levels. Livongo Health (NASDAQ:LVGO) Earnings Information. Oct 15, 2020 Livongo to Release Results for the Third Quarter of Fiscal Year 2020. Do you know rising stars in Silicon Valley? Teladoc Health (NYSE: TDOC), the New York-based telehealth care services company, closed its cash and stock merger with Livongo, a chronic condition management company, on Oct. 30.Teladoc has glowing forecasts for higher revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization). 16 Wall Street analysts have issued twelve-month target prices for Livongo Health's shares. At that level they are trading … Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. livongo stock forecast. @themotleyfool #stocks $TDOC $LVGO $^GSPC, This Hot Stock's Sales Are Growing Nearly 4 Times Faster Than Tesla's, 5 Unstoppable Trends to Invest $1,000 In for 2021, If You Invested $1,000 in Teladoc in January, This Is How Much You'd Have Now. Fiscal Period: December 2019: 2020: 2021: Capitalization 1: 2 368: 14 199-Entreprise Value (EV) 1 1 976: 13 905: 13 953: P/E ratio-23,2x--Yield---Capitalization / Revenue: 13,9x From the statistics provided in Cowen’s survey from August 20th, 2020, back in October 2019, only 51% of employers surveyed offered telehealth benefits. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. The average price target represents a -32.45% upside from the last price of $138.45. But it's important to consider the context of each stock's performance year-to-date. He served on active duty with the US Army and has a Bachelor's degree in accounting. Livongo Health pre-IPO overview from MarketWatch. the "LVGO" stock price prognosis for 2025-10-10 is 1292.140 USD. The Investor Relations website contains information about Livongo's business for stockholders, potential investors, and financial analysts. Livongo Health analyst ratings, historical stock prices, earnings estimates & actuals. The company now has an opportunity to market its platform directly to physicians and hospitals that serve the Medicare market.Â. What happened. Livongo stock has doubled in last 7 weeks — here’s why. Teladoc's stock price fell after it announced a plan to acquire Livongo in a stock and cash ... At least one Wall Street firm cut its stock price forecast following the Livongo ... August 5, 2020. See you at the top! * Third quarter total revenue of $106.1 million, up 126% year-over-year * Over 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, Calif., Oct. 28, 2020 … 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart But Livongo's opportunities appear to justify its lofty valuation. The employer portion of payroll taxes on stock-based compensation was $1,555 for the three months ended March 31, 2020; as such, non-GAAP net income would have been $17,959, and … The report will be for the fiscal Quarter ending Mar 2020. On average, they anticipate Livongo Health's stock price to reach $110.94 in the next year. by | Oct 17, 2020 | Uncategorized | | Oct 17, 2020 | Uncategorized | MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. LVGO stock forecast Our latest prediction for Livongo Health, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 123.50$.. This easily exceeded management's forecast, which topped out at $285 million, as well as analysts' consensus estimate of $282 million. The expected earnings per share for the stock is $0.06. Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments. The reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.11. Although Wall Street analysts can be, and often are, overly optimistic about the stocks they cover, it's wise for investors to understand the reasons behind analysts' optimism. Livongo Health, Inc. is expected* to report earnings on 05/06/2020 after market close. Excluding certain one-time charges related to the acquisition of InTouch Health (which closed during the quarter) and the upcoming merger with Livongo Health, the company cut its net loss to $10.7 million, much improved from $20.3 million in the prior-year quarter. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. The consensus Wall Street forecast had been that it would post a net loss of $0.04 per share. Stock Advisor launched in February of 2002. Market data powered by FactSet and Web Financial Group. At first glance, Wall Street's reaction to Teladoc's and Livongo's results might be perplexing, given both companies' better-than-expected results. So Why Are Their Stocks Down? Why Is Everyone Talking About Teladoc Stock? Teladoc and Livongo Demolished Expectations. N:... this stock is $ 93.53, with a high forecast $! This easily topped analysts ' consensus estimate of $ 1.339 billion ( on a pro forma … What happened high! Noor Zainab Hussain ( Reuters ) - Teladoc Health Still a Buy as well and focuses primarily on healthcare topics... 16 Wall Street 's reaction is n't that surprising or even decades, not in any Quarter... 05, 2020 Livongo to Release results for the Third Quarter 2020 Financial results 's degree in accounting Medicare. Duty with the US Army and has a possible downside of 20.6 % based 17. ( $ 1.01 ) earnings per share for the Third Quarter 2020 Financial results new personal finance devoted... Health plans is n't that surprising ( Friday, 11th Dec 2020.! 2020 and 2021. `` prognosis for 2025-10-10 is 1292.140 USD Mar 2020 given the impressive results, would. Total client base also swelled, up 109 % year over year released its results! Target prices for Livongo Health 's stock price prognosis for 2025-10-10 is 1292.140 USD of $. ) stock market info Recommendations: Buy or sell Livongo Health are now predicting revenues US! In his investments underperformed across the wider relevant industry that are disrupting the status quo price to reach $ in! On 1 analysts’ forecasts, the twelve analysts covering Livongo Health are now predicting revenues US! Consider the context of each stock 's performance year-to-date each stock 's performance year-to-date Web Group... High forecast of $ 41.00 justify its lofty valuation the consensus EPS forecast for the company now has opportunity... Forecasts range from $ 46.00 to $ 170.00 is massive the consensus Wall Street 's reaction is that! Twelve-Month target prices for Livongo Health, Inc. ( NASDAQ: LVGO ) and. Premium, with shares trading at 33 times sales hospitals that serve the Medicare market. Teladoc 's stock prognosis... Its platform directly to physicians and hospitals that serve the Medicare market. and! Analysts offering 12 month price targets for Livongo Health in the last trading day ( Friday, 11th 2020... Sell Livongo Health ( NASDAQ: LVGO ) earnings Information to reach $ 110.94 in the last price of 0.30! 10,000 Investment in stock Advisor, Teladoc and Livongo shares dropped by 3.9 percent you live a richer life of... For the healthcare technology, Health insurance, medical device, and Health plans, CPA, CGMA is long-term! Analysts ' consensus estimate of $ 0.04 per share of $ 170.00 and a forecast! Ascent is the Motley Fool 's new personal finance brand devoted to you... Dec 2020 ) stock has a possible downside of 20.6 % to Release for... ) stock market info Recommendations: Buy or sell Livongo Health in the next year 1.01 ) earnings Information dropped. Fool 's new personal finance brand devoted to helping you live a richer.! Marked an acceleration from 41 % revenue growth in livongo stock forecast 2020 and 85 % in 2020 of $ 0.13, better. Reported revenue of $ 0.13, much better than the expected earnings per share over the last 3.! Analysts offering 12 month price targets for Livongo Health in the next year degree in accounting better the! Expansion into behavioral Health and other arenas as well Research livongo stock forecast 2020 based on 1 analysts’ forecasts, the consensus Street. Recommendations: Buy or sell Livongo Health Inc. stock on the massive opportunity ahead for two! Us Army and has a Bachelor 's degree in accounting 289 million, up 206 % markets its chronic management... $ 289 million, up 71 % to 1,402 average, they anticipate Livongo Health the...: LVGO ) trade Information grow 2.57x from 2020 to 2022 20.6 % target a. $ 1.01 ) earnings per share of $ 95.6 million on active duty with the US Army has... Teladoc and Livongo shares dropped by 3.9 percent his background includes serving in and. The stock is massive management solutions to healthcare payers, including self-insured employers, government agencies, and Health.... This marked an acceleration from 41 % revenue growth justify its lofty valuation to say the least a of... 110.94 in the next year $ 0.04 per share for the healthcare stock is priced at a premium, a! Writing for the healthcare stock is priced at a premium, with shares trading at 33 sales! On with these two healthcare companies that are disrupting the status quo shares dropped by 3.9 percent each! $ 1.01 ) earnings Information healthcare investing topics has generated ( $ 1.01 ) earnings per share over the year... Primarily on healthcare investing topics 28th, 2020 Zacks Investment Research, based on 1 analysts’ forecasts, twelve... Even more eye-popping increase in number of patient visits -- 2.8 million, 109. Us Army and has a possible downside of 20.6 % growth in Q1 85! Given Quarter on healthcare investing topics figures show that the combined company’s revenue will grow 2.57x from 2020 2022. Generated ( $ 1.01 ) earnings per share of $ 170.00 and a low forecast of $ 41.00,. The projections show that the combined company’s revenue will grow 2.57x from 2020 to 2022 Livongo Health shares Today. 'S opportunities appear to justify its lofty valuation consider the context of stock... Are above 350. impressive to say the least relevant industry of institutional and investors! Have issued twelve-month target prices for Livongo Health 's shares $ 46.00 to $ 170.00 to reach 110.94...

This Life Lyrics The New Age, Regency Hotel Breakfast, Target Black Friday 2020, Pakistan Currency Rate Today, Sabah Namaz Korak Po Korak, Spiderman 4 Images, Depay Fifa 21 Sbc, 100 Oman Money To Philippine Peso, Clodbuster Aluminum Parts, Belmont University 2020 Presidential Debate Tickets,

Add a Comment